-+ 0.00%
-+ 0.00%
-+ 0.00%

BioAge Labs Expands BGE-102 Program to Diabetic Macular Edema with Oral NLRP3 Inhibitor

Reuters·01/20/2026 14:01:05

Please log in to view news